Merck–SciBrunch SPR2015: A $400M Preclinical Bet | Lucid Diligence Brief
This Lucid Diligence Brief examines Merck’s licensing deal for SciBrunch’s…
Oncology Today—June 29, 2026
This week’s Oncology update highlights regulatory approvals, access milestones,…
Merck KGaA Bio-Techne Deal | Lucid Diligence Brief
Merck KGaA’s US$11.3bn Bio-Techne acquisition tests workflow depth, integration…
Vaccines Today—June 26, 2026
This week’s Vaccine Research update highlights regulatory progress, early…
Immunology Today—June 24, 2026
This week’s Immunology update highlights regulatory approvals, advancing late-…
Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief
Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…
Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief
Merck and Protillion partner on AI protein design. Assess milestones, platform…
Oncology Today—June 2, 2026
This week’s Oncology update highlights precision-oncology momentum across…
Women’s Health Today—May 27, 2026
This biweekly Women’s Health video recap highlights regulatory progress,…
Oncology Today—May 25, 2026
This week’s Oncology update highlights regulatory progress, biomarker-driven…
Oncology Today—May 18, 2026
This week’s Oncology update highlights regulatory approvals, breakthrough…
